Compass Therapeutics Reports 2024 First Quarter Financial Results and Provides Corporate Update
Go back to Compass Therapeutics Reports 2024 First Quarter Financial Results and Provides Corporate Update| (NASDAQ: CMPX) | Delayed: 2.06 -0.04 (1.9%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.10 | 52 Week High | $ | |||
| Open | $2.04 | 52 Week Low | $ | |||
| Day High | $2.11 | P/E | N/A | |||
| Day Low | $2.04 | EPS | $ | |||
| Volume | 3,098,091 | |||||

